Patricia Kienle, RPh, MPA, FASHP, answers some frequently asked questions related to USP <800> and personal protective equipment (PPE).
USP <800> became official on December 1, 2019, and will become enforceable in the future. Patricia Kienle, RPh, MPA, FASHP, answers some frequently asked questions related to USP <800> and how healthcare facilities should think about minimizing risk of exposure to hazardous drugs (HDs).
The most difficult part of approaching USP <800> can be getting started with the auditing process and assessment of risk. The key idea to remember is that USP <800> compliance is based on an understanding of what will be done with each hazardous drug (HD) received. We invite you to watch the video where Patricia Kienle, RPh, MPA, FASHP, answers frequently asked questions related to USP <800> to prepare your healthcare institution for an assessment of risk.
Patricia C. Kienle is a member of the USP Compounding Expert Committee, but these comments are her own and not those of USP
Talk to a product specialist about products to assist with USP <800> compliance
*
*
Yes, I would like to learn more about Cardinal Health’s products and services by email. I can withdraw my consent or change my preferences by visiting Update Preferences. Visit Privacy Policy for more information about Cardinal Health’s privacy practices.
